Zobrazeno 1 - 10
of 73
pro vyhledávání: '"Daisuke, Kamei"'
Autor:
Tohru Ohmori, Junji Tsurutani, Shinichi Iwai, Daisuke Kamei, Iori Taki-Takemoto, Sojiro Kusumoto, Satoru Arata, Ken-Ichi Fujita, Motoi Ohba, Toshimitsu Yamaoka, Kaori Nakatani
RocR1 and RocR2 cells showed loss of exon 19 deletion and T790M in EGFR following acquisition of rociletinib resistance.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04c3e9463f2688c1d9beec579e7633c2
https://doi.org/10.1158/1535-7163.22504876
https://doi.org/10.1158/1535-7163.22504876
Autor:
Tohru Ohmori, Junji Tsurutani, Shinichi Iwai, Daisuke Kamei, Iori Taki-Takemoto, Sojiro Kusumoto, Satoru Arata, Ken-Ichi Fujita, Motoi Ohba, Toshimitsu Yamaoka, Kaori Nakatani
Proportions of EGFR exon 19 del and T790M alleles in OsiR1-F2M and OsiR2-F2M cells.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92722f327ec7ca8827bbeaf6e4829834
https://doi.org/10.1158/1535-7163.22504864
https://doi.org/10.1158/1535-7163.22504864
Autor:
Tohru Ohmori, Junji Tsurutani, Shinichi Iwai, Daisuke Kamei, Iori Taki-Takemoto, Sojiro Kusumoto, Satoru Arata, Ken-Ichi Fujita, Motoi Ohba, Toshimitsu Yamaoka, Kaori Nakatani
The critical T790M mutation in EGFR, which mediates resistance to first- and second-generation EGFR tyrosine kinase inhibitors (TKI; gefitinib, erlotinib, and afatinib), has facilitated the development of third-generation mutation-selective EGFR TKIs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5738eb2b00fda4164e8cbbd5c251e1a7
https://doi.org/10.1158/1535-7163.c.6537877.v1
https://doi.org/10.1158/1535-7163.c.6537877.v1
Autor:
Motonori Fukumura, Yuzuka Okahisa, Tsuyoshi Maruyama, Aya Kobayashi, Hitomi Yamamoto, Rina Kato, Daisuke Kamei, Yasuna Kobayashi
Publikováno v:
Pharmacometrics / Ōyō Yakuri (0300-8533); Dec2023, Vol. 105 Issue 3/4, p89-92, 4p
Publikováno v:
The Showa University Journal of Medical Sciences. 34:27-32
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::527f0cc37df35c6f0ec44ec34a58360c
https://doi.org/10.15369/sujms.34.27
https://doi.org/10.15369/sujms.34.27
Autor:
Shinichi Iwai, Iori Taki, Kazue Satoh, Yukio Nemoto, Remi Murase, Kazuyoshi Kawazoe, Daisuke Kamei, Satoshi Takamatsu, Hiroaki Nishijima
Publikováno v:
Traditional & Kampo Medicine. 7:30-37
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9da369b613396298fb02fbc2198e5167
https://doi.org/10.1002/tkm2.1238
https://doi.org/10.1002/tkm2.1238
Autor:
Iori Taki, Toshiro Shinke, Makoto Shoji, Hiroshi Saito, Remi Murase, Daisuke Kamei, Shinichi Iwai
Publikováno v:
The Showa University Journal of Medical Sciences. 32:33-42
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5107e6824e3526303b0893fad04b9915
https://doi.org/10.15369/sujms.32.33
https://doi.org/10.15369/sujms.32.33
Autor:
NAOKI SHIBATA, KAZUYOSHI KAWAKAMI, SHIMIZU HISANORI, KAZUO KOBAYASHI, MAYU YUNOKAWA, HIROYUKI KANAO, IORI TAKI, REMI MURASE, DAISUKE KAMEI, MASAKAZU YAMAGUCHI
Publikováno v:
Anticancer research. 42(2)
Carboplatin is a key drug in the treatment of ovarian cancer, but hypersensitivity reactions (HSRs) may occur with repeated use.Thirty-seven ovarian cancer patients treated with carboplatin desensitization therapy were reviewed retrospectively. The t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69cc0b87e27ff5b511fd7fefac38086f
https://pubmed.ncbi.nlm.nih.gov/35093911
https://pubmed.ncbi.nlm.nih.gov/35093911
Autor:
Junji Tsurutani, Iori Taki-Takemoto, Kaori Nakatani, Motoi Ohba, Tohru Ohmori, Toshimitsu Yamaoka, Ken-Ichi Fujita, Daisuke Kamei, Satoru Arata, Shinichi Iwai, Sojiro Kusumoto
Publikováno v:
Molecular Cancer Therapeutics. 18:112-126
The critical T790M mutation in EGFR, which mediates resistance to first- and second-generation EGFR tyrosine kinase inhibitors (TKI; gefitinib, erlotinib, and afatinib), has facilitated the development of third-generation mutation-selective EGFR TKIs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9203621e324746ed6b5c9db24e3b1214
https://doi.org/10.1158/1535-7163.mct-18-0591
https://doi.org/10.1158/1535-7163.mct-18-0591
Publikováno v:
The Showa University Journal of Medical Sciences. 31:125-137
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::84e9c1fcc1939a1480bb653ef3460485
https://doi.org/10.15369/sujms.31.125
https://doi.org/10.15369/sujms.31.125